Marex Group’s Humana HUM Stock Holding History

Marex Group’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-55,000	Closed	-$9.54M	–	1233
2026 Q1	$9.54M	Buy	+55,000	New	+$11.3M	0.06%	163
2025 Q3	–	Sell	-305,000	Closed	-$74.6M	–	922
2025 Q2	$74.6M	Buy	+305,000	New	+$76M	0.65%	36

Other funds holding HUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Eagle Capital Management (New York) New York $32.7B AUM 17.15% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group's HUM Position: Q2 2026 in Review

Marex Group sold out of Humana (HUM) in Q2 2026, closing a stake of 59,754 shares — an estimated $10.4M sold.

Marex Group first reported a position in HUM in Q1 2023 and held it in 10 quarters. The position peaked at $74.7M in Q2 2025. 925 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

Marex Group reported no remaining Humana position as of Q2 2026 after selling out during the quarter.
Marex Group sold 59,754 Humana shares in Q2 2026, an estimated $10.4M.
Marex Group first reported a position in Humana in Q1 2023 and held it in 10 quarters.
Marex Group's Humana position peaked at $74.7M in Q2 2025.
925 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.